Baucus Kills $750M Clinical Lab Tax Provision

By Kirell Lakhman

Sen. Max Baucus has ended his quest to levy a new $750 million annual performance tax on clinical labs, according to a new mark of the bill.

However, a separate provision in his Senate bill would cut the Medicare lab fee schedule by 1.75 percentage points from 2011 through 2015, according to G-2 Reports.

Shares in LabCorp and Quest surged on the news. LabCorp stock was up 3.67 percent at 65.69 in late-afternoon trading, while Quest shares were up 3.77 percent at $53.43.

Baucus is chairman of the Senate Finance Committee, which has been drafting the chamber’s version of a health-care reform package sought by the Obama Administration. Baucus’ decision to remove the new fees comes two weeks after they appeared as part of a draft proposal to pay for the plan, which would cost around $900 billion.

The proposed tax was seen as a blow to clinical labs in the US. Today, during a presentation at UBS’ annual life-science conference in New York, LabCorp CEO David King called the tax “draconian,” “enormously outsized,” and “confiscatory.”

Yesterday, members of the finance committee began a swift campaign to introduce amendments that would rid Baucus’ plan of the new fees.